PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)
Author:
Gerald F. Watts,Dick C. Chan,Jing Pang,Louis Ma,Qidi Ying,Shashi Aggarwal,Santica M. Marcovina,P. Hugh R. Barrett
© 2020 Elsevier Inc. All rights reserved.